CIRC(01763): The exhale diagnostics product has been awarded the national pharmaceutical industry single event championship.
China Tongfu (01763) issued an announcement that recently, its subsidiary, Shenzhen Zhonghe Haideweibio Technology Co., Ltd...
CIRC (01763) announced that its subsidiary, Shenzhen Zhonghe Hede Wei Biotechnology Co., Ltd., has recently been selected as a national-level manufacturing enterprise and awarded the "Pharmaceutical Industry Champion" title, thanks to its core product "Urea [13C/14C] Breath Test Kit."
CIRC has always focused on the urea [13C] and [14C] breath test diagnostic segment in the medical isotope application field. The urea [13C] and [14C] breath test products produced by the company are used to detect Helicobacter pylori, with coverage of over 20,000 domestic end customers and sales to 90 countries and regions. The market share has consistently ranked at the forefront of the industry for many years.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


